Case reportLeft ventricular non-compaction cardiomyopathy associated with epidermolysis bullosa simplex with muscular dystrophy and PLEC1 mutation
Introduction
Plectin is a large, 466 kD, linker protein involved in cytoskeletal organization which is expressed in a variety of tissues including epithelia, skeletal muscle and myocardium [1]. Plectin mutations lead to epidermolysis bullosa simplex (EBS) subtypes associated with muscular dystrophy (EBS-MD) [2], congenital myasthenic syndrome [3], and pyloric atresia [3].
EBS-MD is an autosomal recessive disorder characterized by skin fragility and delayed onset muscular dystrophy, although there is significant heterogeneity in the clinical phenotype. The dermatologic manifestations vary significantly in severity and include neonatal skin fragility, nail abnormalities and mucosal manifestations ranging from no mucosal involvement to severe involvement with associated tracheal or urethral tract complications [4]. The muscular dystrophy is similarly variable in age of onset and severity and is characterized by proximal or distal muscle weakness which presents from infancy [5] to the fourth decade of life [6]. Three cases with myocardial involvement have been reported: a 33-year-old woman [7] with an ejection fraction of 46% (normal 55–70%) and atrial fibrillation; a 25-year-old with mild left ventricular hypertrophy [8]; a 40-year-old [8] with dilated cardiomyopathy. Here, we describe a case of left ventricular non-compaction cardiomyopathy in an 18-year-old male with EBS-MD due to a homozygous nonsense mutation in PLEC1.
Section snippets
Case report
The patient is an 18-year-old African-American male who was born at full term to an 18-year-old mother following an uncomplicated pregnancy. The maternal family history revealed no evidence of dermatologic, neuromuscular or cardiac abnormalities. The identity of the father is unknown. The patient was noted to have mild blistering of his elbow at birth. Subsequent biopsy revealed a diagnosis of EBS. He had no complications in the neonatal period and was followed by a general pediatrician. The
Discussion
The case is the first description of left ventricular non-compaction in a patient with EBS-MD and thus expands the phenotypic manifestations in patients with plectinopathies.
Plectin is a member of the plakin family of linker proteins involved in cytoskeletal organization and is widely expressed in a variety of tissues including epithelia, skeletal muscle and myocardium [1]. The pleiotropic dermatologic and neuromuscular phenotypes are consistent with plectin's numerous binding partners. The
References (29)
- et al.
Congenital muscular dystrophy, myasthenic symptoms and epidermolysis bullosa simplex (EBS) associated with mutations in the PLEC1 gene encoding plectin
Neuromuscul Disord
(2010) - et al.
PLEC1 mutations underlie adult-onset dilated cardiomyopathy in epidermolysis bullosa simplex with muscular dystrophy
J Invest Dermatol
(2010) - et al.
Epidermolysis bullosa simplex associated with severe mucous membrane involvement and novel mutations in the plectin gene
J Invest Dermatol
(2000) - et al.
What do we know about the “malignant form” of early repolarization
J Am Coll Cardiol
(2013) - et al.
Immunogold EM reveals a close association of plectin and the desmin cytoskeleton in human skeletal muscle
Eur J Cell Biol
(1999) - et al.
Plectin interacts with the rod domain of type III intermediate filament proteins desmin and vimentin
Eur J Cell Biol
(2011) - et al.
Long-term follow-up of 34 adults with isolated left ventricular noncompaction: a distinct cardiomyopathy with poor prognosis
J Am Coll Cardiol
(2000) - et al.
Left ventricular hypertrabeculation/noncompaction and association with additional cardiac abnormalities and neuromuscular disorders
Am J Cardiol
(2002) - et al.
Mutations in Cypher/ZASP in patients with dilated cardiomyopathy and left ventricular non-compaction
J Am Coll Cardiol
(2003) - et al.
Familial dilated cardiomyopathy and isolated left ventricular noncompaction associated with lamin A/C gene mutations
Am J Cardiol
(2004)